Author

Tine B. Stensbøl

Observed names: Stensbol, T.B., Stensbøl, Tine B, T B Stensbøl, T. B. STENSBOEL, T. Bryan Stensbøl, T. Stensbol, T.B. Stensbol, T.B. Stensbøl, TINE B. STENSBØL, Tine B Stensbol, Tine B Stensbøl, Tine B. Stensboel, Tine Bryan Stensboel, Tine Bryan Stensbol, Tine Bryan Stensbøl, Tine Stensbol, Tine Stensbøl, Tine B. Stensbøl

Institution: Lundbeck (Denmark)

Observed institutions: University of Messina, Otsuka (Japan), University of Copenhagen, Lundbeck (Denmark), University of Oslo, Novo Nordisk (Denmark), University of Milan, Aarhus University, Kyoto University, University of Cambridge, University of Pavia, Mental Health Services, Otsuka (United States), Centro de Investigación Biomédica en Red de Salud Mental, Institut d'Investigacions Biomèdiques de Barcelona, Lundbeck (United States), Université Blaise Pascal, Otsuka Pharmaceutical Development & Commercialization, Inc. (United States), Columbia University

OpenAlex ID: A5110191635

CNVs conferring risk of autism or schizophrenia affect cognition in controls

2013 · Hreinn Stefansson, Andreas Meyer-Lindenberg, et al. · Nature · 713

Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

2011 · Benny Bang-Andersen, Thomas Ruhland, et al. · Journal of Medicinal Chemistry · 621

Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator

2014 · Kenji Maeda, Haruhiko Sugino, et al. · Journal of Pharmacology and Experimental Therapeutics · 382

Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

2011 · A. Mørk, A. Pehrson, et al. · Journal of Pharmacology and Experimental Therapeutics · 285

Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator

2014 · Kenji Maeda, Linda Lerdrup, et al. · Journal of Pharmacology and Experimental Therapeutics · 137

Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis

2012 · Katherine E. Tansey, Michel Guipponi, et al. · PLoS Medicine · 137

Novel Class of Potent 4-Arylalkyl Substituted 3-Isoxazolol GABAA Antagonists: Synthesis, Pharmacology, and Molecular Modeling

2002 · Bente Frølund, Anne T. Jørgensen, et al. · Journal of Medicinal Chemistry · 133

Discovery of the First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1

2009 · Anders A. Jensen, Mette N. Erichsen, et al. · Journal of Medicinal Chemistry · 88

Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice

2016 · Michael Didriksen, Kim Fejgin, et al. · Journal of Psychiatry and Neuroscience · 75

PDF

The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?

2015 · Leslie Citrome, Tine Bryan Stensbøl, et al. · Expert Review of Neurotherapeutics · 64

Design, Synthesis, and Pharmacological Characterization ofN- andO-Substituted 5,6,7,8-Tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol Analogues: Novel 5-HT2A/5-HT2CReceptor Agonists with Pro-Cognitive Properties

2013 · Anders A. Jensen, Niels Plath, et al. · Journal of Medicinal Chemistry · 63

Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA

1999 · Tine B Stensbøl, Lars Borre, et al. · European Journal of Pharmacology · 56

A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment

2016 · Simon R. O. Nilsson, Pau Celada, et al. · Psychopharmacology · 54

PDF

Chemo-Enzymatic Synthesis of a Series of 2,4-Syn-Functionalized (S)-Glutamate Analogues: New Insight into the Structure−Activity Relation of Ionotropic Glutamate Receptor Subtypes 5, 6, and 7

2008 · Emanuelle Sagot, Darryl S. Pickering, et al. · Journal of Medicinal Chemistry · 54

(S)-Homo-AMPA, a Specific Agonist at the mGlu6 Subtype of Metabotropic Glutamic Acid Receptors

1997 · Haleh Ahmadian, Birgitte Nielsen, et al. · Journal of Medicinal Chemistry · 54

Novel 1-Hydroxyazole Bioisosteres of Glutamic Acid. Synthesis, Protolytic Properties, and Pharmacology

2001 · Tine B. Stensbøl, Peter Uhlmann, et al. · Journal of Medicinal Chemistry · 53

Three-Dimensional Structure of the Ligand-Binding Core of GluR2 in Complex with the Agonist ( S ) - ATPA: Implications for Receptor Subunit Selectivity

2003 · Marie-Louise Lunn, Anders Hogner, et al. · Journal of Medicinal Chemistry · 51

Ibotenic acid and thioibotenic acid: a remarkable difference in activity at group III metabotropic glutamate receptors

2004 · Mette B. Hermit, Jeremy R. Greenwood, et al. · European Journal of Pharmacology · 49

Potent 4-Aryl- or 4-Arylalkyl-Substituted 3-Isoxazolol GABAA Antagonists: Synthesis, Pharmacology, and Molecular Modeling

2004 · Bente Frølund, Lars S. Jensen, et al. · Journal of Medicinal Chemistry · 48

Synthesis and Enantiopharmacology of New AMPA-Kainate Receptor Agonists

1999 · Paola Conti, Marco De Amici, et al. · Journal of Medicinal Chemistry · 42

Plaque Deposition Dependent Decrease in 5-HT2A Serotonin Receptor in AβPPswe/PS1dE9 Amyloid Overexpressing Mice

2010 · Peter Holm, Anders Ettrup, et al. · Journal of Alzheimer s Disease · 41

The AMPA Receptor Binding Site: Focus on Agonists and Competitive Antagonists

2002 · Tine Stensbol, Ulf Madsen, et al. · Current Pharmaceutical Design · 41

An acetylcholine alpha7 positive allosteric modulator rescues a schizophrenia-associated brain endophenotype in the 15q13.3 microdeletion, encompassing CHRNA7

2016 · Natalia Gass, Wolfgang Weber-Fahr, et al. · European Neuropsychopharmacology · 38

PDF

A Novel Class of Potent 3-Isoxazolol GABAAAntagonists: Design, Synthesis, and Pharmacology

2000 · Bente Frølund, Lena Tagmose, et al. · Journal of Medicinal Chemistry · 37

4-Aryl-5-(4-Piperidyl)-3-Isoxazolol GABAA Antagonists: Synthesis, Pharmacology, and Structure−Activity Relationships

2007 · Bente Frølund, Lars S. Jensen, et al. · Journal of Medicinal Chemistry · 35

Works count: 95

Citation count: 4,136

H-index: 30

I10-index: 59